These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 9450766)
1. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Zerr I; Bodemer M; Gefeller O; Otto M; Poser S; Wiltfang J; Windl O; Kretzschmar HA; Weber T Ann Neurol; 1998 Jan; 43(1):32-40. PubMed ID: 9450766 [TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008. Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221 [TBL] [Abstract][Full Text] [Related]
3. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616 [TBL] [Abstract][Full Text] [Related]
4. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease]. Sáiz A; Marín C; Tolosa E; Graus F Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Zerr I; Bodemer M; Otto M; Poser S; Windl O; Kretzschmar HA; Gefeller O; Weber T Lancet; 1996 Sep; 348(9031):846-9. PubMed ID: 8826809 [TBL] [Abstract][Full Text] [Related]
6. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883 [TBL] [Abstract][Full Text] [Related]
7. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease]. Bernheimer H; Gatterbauer B; Radbauer C; Budka H Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349 [TBL] [Abstract][Full Text] [Related]
8. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282 [TBL] [Abstract][Full Text] [Related]
10. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Huang N; Marie SK; Livramento JA; Chammas R; Nitrini R Neurology; 2003 Aug; 61(3):354-7. PubMed ID: 12913197 [TBL] [Abstract][Full Text] [Related]
11. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Green AJ Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099 [TBL] [Abstract][Full Text] [Related]
12. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay. Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479 [TBL] [Abstract][Full Text] [Related]
14. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392 [TBL] [Abstract][Full Text] [Related]
15. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008 [TBL] [Abstract][Full Text] [Related]
16. [Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report]. Golańska E; Hułas-Bigoszewska K; Sikorska B; Liberski PP Neurol Neurochir Pol; 2005; 39(5):358-65. PubMed ID: 16273459 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Castellani RJ; Colucci M; Xie Z; Zou W; Li C; Parchi P; Capellari S; Pastore M; Rahbar MH; Chen SG; Gambetti P Neurology; 2004 Aug; 63(3):436-42. PubMed ID: 15304573 [TBL] [Abstract][Full Text] [Related]
18. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course. Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program. Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S Prion; 2015; 9(2):136-43. PubMed ID: 25996401 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Van Everbroeck B; Boons J; Cras P Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]